Difficulty: Medium
Average Score: 79%
Practice
A 65-year-old male with heart failure is prescribed ivabradine. Ivabradine works by:
Correct answer
B
Rationale
In the context of lifespan pharmacology, it is crucial to understand the mechanism of action of medications prescribed to older adults, as they may have different physiological responses compared to younger individuals.
In this case, the correct answer is B) Inhibiting the If current in the sinoatrial node. Ivabradine is a medication used to lower heart rate in conditions like heart failure. It specifically targets the If current in the sinoatrial node, which is responsible for the initiation of cardiac pacemaker activity. By inhibiting this current, ivabradine reduces the heart rate without affecting other aspects of cardiac function, making it a valuable option for patients with heart failure.
Option A) Increasing heart rate by stimulating the sinoatrial node is incorrect because ivabradine actually reduces heart rate by inhibiting the If current.
Option C) Blocking beta-adrenergic receptors in the heart is not the mechanism of action of ivabradine. Beta-blockers work through this mechanism but not ivabradine.
Option D) Increasing myocardial contractility is also incorrect as ivabradine does not directly affect myocardial contractility.
Understanding the specific mechanism of action of medications like ivabradine is essential for healthcare providers to make informed decisions when prescribing drugs to older adults with complex medical conditions such as heart failure. It highlights the importance of tailoring pharmacological treatments to individual patient needs based on the drug's specific actions within the body.
In this case, the correct answer is B) Inhibiting the If current in the sinoatrial node. Ivabradine is a medication used to lower heart rate in conditions like heart failure. It specifically targets the If current in the sinoatrial node, which is responsible for the initiation of cardiac pacemaker activity. By inhibiting this current, ivabradine reduces the heart rate without affecting other aspects of cardiac function, making it a valuable option for patients with heart failure.
Option A) Increasing heart rate by stimulating the sinoatrial node is incorrect because ivabradine actually reduces heart rate by inhibiting the If current.
Option C) Blocking beta-adrenergic receptors in the heart is not the mechanism of action of ivabradine. Beta-blockers work through this mechanism but not ivabradine.
Option D) Increasing myocardial contractility is also incorrect as ivabradine does not directly affect myocardial contractility.
Understanding the specific mechanism of action of medications like ivabradine is essential for healthcare providers to make informed decisions when prescribing drugs to older adults with complex medical conditions such as heart failure. It highlights the importance of tailoring pharmacological treatments to individual patient needs based on the drug's specific actions within the body.